What people are saying - Write a review
We haven't found any reviews in the usual places.
The History of Drug Discovery Development
New Studies on Market Definition Concentration
Commentary Douglas L Cocks
11 other sections not shown
accounting rates activities American Enterprise Institute analysis antibiotics antiinfective average basic research brand name ceutical changes chemical entities clinical testing clinical trials Cocks Comanor compulsory licensing concentration costs demand depreciation Development and Marketing development expenditures dollars Drug Development drug firms drug innovation drug prices drug products effects entering clinical entry barriers estimated Ethical Drug Industry Ethical Pharmaceutical Industry expected Grabowski Hornbrook impact increase instability index Institute for Public intangible capital investment Journal licensing long-term animal tests manufacturing market share marketing approval measured ment NCE entering NDA submission networth oligopoly outlays patent percent period pharma pharmaceutical firms Pharmaceutical Industry Pharmaceutical Innovation pharmacist physicians post-IND preclinical prescription drugs price competition product differentiation product innovation promotion proposed Public Policy Research R&D expenditures rates of return ratio reduce regulatory relatively research and development studies Table Telser tetracycline therapeutic markets tion Washington